GlassScriptPhysician profile
David H Eisenberg
NPI 1245394519
$3,987.82
in general payments reported to CMS, 2019-2025
11 companies · $33.33 in 2025
The $33.33 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $35.41 · 2021: $1,532 · 2022: $1,061 · 2023: $826 · 2024: $189 · 2025: $33.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,301.79 | 2022-2023 | |
| Pylant Medical | $1,296.26 | 2019-2024 | |
| Heron Therapeutics, INC. | $334.69 | 2023 | Zynrelef |
| Anika Therapeutics, INC. | $216.80 | 2022-2023 | Tactoset |
| Integra Lifesciences Corporation | $203.76 | 2019-2020 | |
| Paragon 28, INC. | $193.33 | 2021 | |
| Biowound Solutions, INC. | $120.63 | 2024 | Bio-Connekt |
| Wright Medical Technology, INC. | $118.42 | 2019 | |
| Ossio INC | $87.59 | 2021 | |
| Smith+Nephew, INC. | $81.22 | 2021-2024 | Hat-Trick |
| Polynovo North America LLC | $33.33 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.